Supernus (SUPN) Sr. VP Padmanabh Bhatt Receives Award of 2,500 Shares

What Happened Padmanabh P. Bhatt, Sr. VP of IP and Chief Scientific Officer at Supernus Pharmaceuticals (SUPN), was reported on a Form 4 to have acquired 2,500 shares via an award/grant on July 29, 2026. The filing lists the acquisition as a derivative award at $0.00 per share (total reported value $0), indicating these were stock-based compensation units rather than an open-market purchase.

Key Details

• Transaction date: 2026-07-29 (reported on Form 4 filed 2026-07-31).
• Transaction type/code: A = Award/Grant (derivative).
• Shares acquired: 2,500; reported price per share: $0.00; reported total value: $0.
• Shares owned after transaction: not disclosed in the provided filing details.
• Footnote: The award traces to Performance Share Units granted on Feb 19, 2025; a portion vested upon achievement of individual performance objectives established May 3, 2025.
• Filing timeliness: Filed two days after the transaction date (appears timely under Form 4 reporting rules).

Context This was an equity compensation vesting event (performance-share units converting to reported shares), not a market purchase or sale. Such awards are compensation/retention tools and do not by themselves indicate an insider buying or selling stock in the open market.